HRP20100208T1 - Postupak liječenja akutnog rinosinusitisa - Google Patents
Postupak liječenja akutnog rinosinusitisa Download PDFInfo
- Publication number
- HRP20100208T1 HRP20100208T1 HR20100208T HRP20100208T HRP20100208T1 HR P20100208 T1 HRP20100208 T1 HR P20100208T1 HR 20100208 T HR20100208 T HR 20100208T HR P20100208 T HRP20100208 T HR P20100208T HR P20100208 T1 HRP20100208 T1 HR P20100208T1
- Authority
- HR
- Croatia
- Prior art keywords
- mometasone furoate
- use according
- amount
- ranges
- mometasone
- Prior art date
Links
- 206010001076 Acute sinusitis Diseases 0.000 title claims 2
- 238000000034 method Methods 0.000 title abstract 2
- 229960002744 mometasone furoate Drugs 0.000 claims abstract 16
- WOFMFGQZHJDGCX-ZULDAHANSA-N mometasone furoate Chemical compound O([C@]1([C@@]2(C)C[C@H](O)[C@]3(Cl)[C@@]4(C)C=CC(=O)C=C4CC[C@H]3[C@@H]2C[C@H]1C)C(=O)CCl)C(=O)C1=CC=CO1 WOFMFGQZHJDGCX-ZULDAHANSA-N 0.000 claims abstract 16
- 201000010099 disease Diseases 0.000 claims abstract 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract 4
- 239000002245 particle Substances 0.000 claims abstract 4
- 210000002345 respiratory system Anatomy 0.000 claims 2
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 229940088710 antibiotic agent Drugs 0.000 claims 1
- 239000007900 aqueous suspension Substances 0.000 claims 1
- 229960004123 mometasone furoate monohydrate Drugs 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 238000009097 single-agent therapy Methods 0.000 abstract 1
- 201000009890 sinusitis Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Adhesives Or Adhesive Processes (AREA)
Abstract
Upotreba aerosoliziranih čestica mometazon-furoata u pripravi farmaceutskog pripravka za liječenje akutnog rinosinusitisa kod gornjih dišnih puteva kod pacijenata pogođenih navedenom bolešću, bez istodobne primjene antibiotika, naznačena time što navedeni pripravak se formulira za primjenu najmanje jednom dnevno na površine navedenih dišnih puteva kod navedenih pacijenata količine aerosoliziranih čestica mometazon-furoata djelotvorne u liječenju navedene bolesti. Patent sadrži još 11 patentnih zahtjeva.
Claims (12)
1. Upotreba aerosoliziranih čestica mometazon-furoata u pripravi farmaceutskog pripravka za liječenje akutnog rinosinusitisa kod gornjih dišnih puteva kod pacijenata pogođenih navedenom bolešću, bez istodobne primjene antibiotika, naznačena time što navedeni pripravak se formulira za primjenu najmanje jednom dnevno na površine navedenih dišnih puteva kod navedenih pacijenata količine aerosoliziranih čestica mometazon-furoata djelotvorne u liječenju navedene bolesti.
2. Upotreba u skladu s patentnim zahtjevom 1, naznačena time što navedena količina mometazon-furoata se kreće u rasponu od otprilike 25 µg do otprilike 1600 µg aerosoliziranih čestica mometazon-furoata.
3. Upotreba u skladu s patentnim zahtjevom 2, naznačena time što navedena količina mometazon-furoata se kreće u rasponu od otprilike 25 µg do otprilike 800 µg.
4. Upotreba u skladu s patentnim zahtjevom 3, naznačena time što navedena količina mometazon-furoata se kreće u rasponu od otprilike 25 µg do otprilike 400 µg.
5. Upotreba u skladu s patentnim zahtjevom 4, naznačena time što navedena količina mometazon-furoata se kreće u rasponu od otprilike 25 µg do otprilike 200 µg.
6. Upotreba u skladu s patentnim zahtjevom 5, naznačena time što navedena količina mometazon-furoata se kreće u rasponu od otprilike 25 µg do otprilike 100 µg.
7. Upotreba u skladu s patentnim zahtjevom 1, naznačena time što navedena količina mometazon-furoata je otprilike 100 µg, 200 µg ili 400 µg.
8. Upotreba u skladu s patentnim zahtjevom 1, naznačena time što navedenu količinu mometazon-furoata se formulira za primjenu dvaput dnevno.
9. Upotreba u skladu s patentnim zahtjevom 1, naznačena time što mometazon-furoat je mometazon-furoat monohidrat.
10. Upotreba u skladu s patentnim zahtjevom 1, naznačena time što mometazon-furoat se formulira za primjenu u obliku vodene suspenzije.
11. Upotreba u skladu s patentnim zahtjevom 1, naznačena time što mometazon-furoat se formulira za primjenu u obliku suhog praha.
12. Upotreba u skladu s patentnim zahtjevom 11, naznačena time što mometazon-furoat je bezvodni mometazon-furoat.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53783004P | 2004-01-21 | 2004-01-21 | |
PCT/US2005/002105 WO2005072704A2 (en) | 2004-01-21 | 2005-01-19 | Method of treating acute rhinosinusitis |
Publications (2)
Publication Number | Publication Date |
---|---|
HRP20100208T1 true HRP20100208T1 (hr) | 2010-05-31 |
HRP20100208T8 HRP20100208T8 (hr) | 2010-06-30 |
Family
ID=34825945
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20100208T HRP20100208T8 (hr) | 2004-01-21 | 2010-04-13 | Postupak liječenja akutnog rinosinusitisa |
Country Status (16)
Country | Link |
---|---|
US (2) | US20050186144A1 (hr) |
EP (2) | EP1711164B1 (hr) |
JP (2) | JP4976139B2 (hr) |
AT (1) | ATE461693T1 (hr) |
CA (1) | CA2554064A1 (hr) |
CY (1) | CY1110620T1 (hr) |
DE (1) | DE602005020113D1 (hr) |
DK (1) | DK1711164T3 (hr) |
ES (2) | ES2426957T3 (hr) |
HR (1) | HRP20100208T8 (hr) |
MX (1) | MXPA06008240A (hr) |
PL (1) | PL1711164T3 (hr) |
PT (1) | PT1711164E (hr) |
RS (1) | RS51335B (hr) |
SI (1) | SI1711164T1 (hr) |
WO (1) | WO2005072704A2 (hr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE461693T1 (de) * | 2004-01-21 | 2010-04-15 | Schering Corp | Verfahren zur behandlung von akuten rhinosinusitis |
AU2007311607A1 (en) * | 2006-10-19 | 2008-04-24 | Cipla Limited | Pharmaceutical compositions and nasal spray incorporating anhydrous mometasone furoate |
TWI411121B (zh) * | 2010-03-11 | 2013-10-01 | Ind Tech Res Inst | 光吸收層之製造方法及應用其之太陽能電池結構 |
EP2938339B1 (en) * | 2012-12-27 | 2020-08-19 | Massachusetts Eye & Ear Infirmary | Treatment of rhinosinusitis with p-glycoprotein inhibitors |
JP7085485B2 (ja) | 2016-01-15 | 2022-06-16 | マサチューセッツ アイ アンド イヤー インファーマリー | 分泌型p-糖タンパク質は、慢性鼻副鼻腔炎の非侵襲的バイオマーカーである |
AU2021297174A1 (en) * | 2020-06-21 | 2023-02-02 | Massachusetts Eye And Ear Infirmary | Combination verapamil and mometasone therapy for the treatment of chronic rhinosinusitis |
JP2024049405A (ja) * | 2021-02-22 | 2024-04-10 | 興和株式会社 | 新規吸入剤 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE8790T1 (de) | 1981-02-02 | 1984-08-15 | Schering Corporation | Aromatische heterocyclische steroidester, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten. |
US4731447A (en) | 1985-05-13 | 1988-03-15 | Schering Corporation | Process for preparing piperidylidene dihydro-dibenzo(a,d)-cycloheptenes or aza-derivatives thereof |
US4873335A (en) | 1986-03-12 | 1989-10-10 | Schering Corporation | 3-phenethyl-2-benzene-amides or aza-derivatives thereof |
DE69233150T2 (de) | 1991-06-10 | 2004-06-24 | Schering Corp. | Fluorchlorkohlenwasserstoffreie Aerosolformulierungen |
ATE203900T1 (de) * | 1991-06-10 | 2001-08-15 | Schering Corp | Fluorchlorkohlenwasserstofffreie aerosolformulierungen |
US6127353A (en) * | 1991-09-06 | 2000-10-03 | Schering Corporation | Mometasone furoate monohydrate, process for making same and pharmaceutical compositions |
PE44995A1 (es) * | 1994-01-27 | 1995-12-18 | Schering Corp | Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias |
US5837699A (en) * | 1994-01-27 | 1998-11-17 | Schering Corporation | Use of mometasone furoate for treating upper airway passage diseases |
US6068832A (en) | 1996-08-29 | 2000-05-30 | Schering Corporation | Chlorofluorocarbon-free mometasone furoate aerosol formulations |
US5837713A (en) * | 1997-02-26 | 1998-11-17 | Mayo Foundation For Medical Education And Research | Treatment of eosinophil-associated pathologies by administration of topical anesthetics and glucocorticoids |
US6503537B2 (en) * | 1997-03-20 | 2003-01-07 | Schering Corporation | Preparation of powder agglomerates |
US6495167B2 (en) * | 1997-03-20 | 2002-12-17 | Schering Corporation | Preparation of powder agglomerates |
US6187765B1 (en) | 1997-10-09 | 2001-02-13 | Schering Corporation | Mometasone furoate suspensions for nebulization |
US6297227B1 (en) * | 1998-09-10 | 2001-10-02 | Schering Corporation | Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines |
SE9803770D0 (sv) * | 1998-11-05 | 1998-11-05 | Astra Ab | Dry powder pharmaceutical formulation |
US6465581B1 (en) * | 2001-01-24 | 2002-10-15 | The Goodyear Tire & Rubber Company | Silica reinforced rubber composition which contains stabilized unsymmetrical coupling agents and article of manufacture, including a tire, having at least one component comprised of such rubber composition |
AR036358A1 (es) * | 2001-08-28 | 2004-09-01 | Schering Corp | Un inhalador de dosis medidas que contiene una formulacion de suspension en aerosol para inhalacion, un proceso para la produccion de la formulacion, el producto y el uso de una formulacion para la manufactura de un medicamento de asma |
EP1542753B1 (en) * | 2002-08-23 | 2007-02-07 | Schering Corporation | Pharmaceutical compositions |
US20040081625A1 (en) * | 2002-10-21 | 2004-04-29 | Schering Corporation | Nasal formulations for the treatment of allergies |
US8912174B2 (en) * | 2003-04-16 | 2014-12-16 | Mylan Pharmaceuticals Inc. | Formulations and methods for treating rhinosinusitis |
US20040235807A1 (en) * | 2003-05-21 | 2004-11-25 | Weinrich Karl P. | Formulations including a topical decongestant and a topical corticosteroid suitable for nasal administration and method for treating obstructive sleep apnea |
WO2005041931A2 (en) * | 2003-10-20 | 2005-05-12 | Schering Corporation | Pharmaceutical aerosol compositions |
ATE461693T1 (de) * | 2004-01-21 | 2010-04-15 | Schering Corp | Verfahren zur behandlung von akuten rhinosinusitis |
EP2651494B1 (en) | 2010-12-13 | 2017-02-15 | Pacesetter, Inc. | Delivery catheter |
US9106249B1 (en) | 2014-09-04 | 2015-08-11 | Semtech Corporation | Calibration of a time-interleaved analog-to-digital converter |
-
2005
- 2005-01-19 AT AT05711867T patent/ATE461693T1/de active
- 2005-01-19 ES ES10003076T patent/ES2426957T3/es active Active
- 2005-01-19 CA CA002554064A patent/CA2554064A1/en not_active Abandoned
- 2005-01-19 MX MXPA06008240A patent/MXPA06008240A/es active IP Right Grant
- 2005-01-19 WO PCT/US2005/002105 patent/WO2005072704A2/en active Application Filing
- 2005-01-19 ES ES05711867T patent/ES2340777T3/es active Active
- 2005-01-19 DE DE602005020113T patent/DE602005020113D1/de active Active
- 2005-01-19 EP EP05711867A patent/EP1711164B1/en active Active
- 2005-01-19 PL PL05711867T patent/PL1711164T3/pl unknown
- 2005-01-19 SI SI200531000T patent/SI1711164T1/sl unknown
- 2005-01-19 US US11/038,343 patent/US20050186144A1/en not_active Abandoned
- 2005-01-19 PT PT05711867T patent/PT1711164E/pt unknown
- 2005-01-19 EP EP10003076.6A patent/EP2201936B1/en not_active Revoked
- 2005-01-19 JP JP2006551345A patent/JP4976139B2/ja not_active Expired - Fee Related
- 2005-01-19 DK DK05711867.1T patent/DK1711164T3/da active
- 2005-01-19 RS RSP-2010/0236A patent/RS51335B/en unknown
-
2008
- 2008-01-28 JP JP2008016970A patent/JP2008110991A/ja active Pending
- 2008-07-11 US US12/171,989 patent/US20090022671A1/en not_active Abandoned
-
2010
- 2010-04-13 HR HR20100208T patent/HRP20100208T8/hr unknown
- 2010-04-28 CY CY20101100378T patent/CY1110620T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
JP2007518817A (ja) | 2007-07-12 |
PL1711164T3 (pl) | 2010-09-30 |
CA2554064A1 (en) | 2005-08-11 |
CY1110620T1 (el) | 2015-04-29 |
RS51335B (en) | 2011-02-28 |
JP4976139B2 (ja) | 2012-07-18 |
DE602005020113D1 (de) | 2010-05-06 |
MXPA06008240A (es) | 2006-08-31 |
US20050186144A1 (en) | 2005-08-25 |
ATE461693T1 (de) | 2010-04-15 |
ES2340777T3 (es) | 2010-06-09 |
EP2201936A1 (en) | 2010-06-30 |
ES2426957T3 (es) | 2013-10-28 |
DK1711164T3 (da) | 2010-07-19 |
HRP20100208T8 (hr) | 2010-06-30 |
PT1711164E (pt) | 2010-06-28 |
US20090022671A1 (en) | 2009-01-22 |
WO2005072704A3 (en) | 2006-07-20 |
EP1711164B1 (en) | 2010-03-24 |
JP2008110991A (ja) | 2008-05-15 |
EP2201936B1 (en) | 2013-06-19 |
SI1711164T1 (sl) | 2010-06-30 |
WO2005072704A2 (en) | 2005-08-11 |
EP1711164A2 (en) | 2006-10-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20100208T1 (hr) | Postupak liječenja akutnog rinosinusitisa | |
RU2015138796A (ru) | Способы и составы для лечения респираторных заболеваний | |
BR112015029512A2 (pt) | derivados de pirazolopirrolidina e seu uso no tratamento de doenças | |
BR112015029491A2 (pt) | derivados de imidazopirrolidinona e seu uso no tratamento de doença | |
BRPI0507966A (pt) | uso de meloxicam para o tratamento de doenças respiratórias em porcos | |
NO20082643L (no) | Isokinolinaminopyrazolderivater, deres fremstilling og anvendelse som farmasoytiske midler for behandling av kreft | |
BR112017010551A2 (pt) | composto, métodos para ativação de guanilato ciclase solúvel, para tratamento de uma ou mais condições selecionadas a partir de uma doença em um paciente e para tratamento de uma doença ou condição, composição farmacêutica, uso de um composto, e, medicamento. | |
FR2903107B1 (fr) | Derives d'imidazopyridine-2-carboxamides, leur preparation et leur application en therapeutique | |
HK1156847A1 (en) | Pharmaceutical formulations and methods for treating respiratory tract infections | |
ME02495B (me) | Tretman poremećaja koji su u vezi sa bdnf primenom lakvinimoda | |
BR112015029401A8 (pt) | derivados de pirazolo-pirrolidin-4-ona, seus usos, e composição e combinação farmacêuticas | |
BRPI0517891A (pt) | composições compreendendo azelastina e métodos de uso das mesmas | |
NO20024708D0 (no) | Behandling av respiratoriske sykdommer | |
JP2016513688A5 (hr) | ||
PT2322525E (pt) | Derivados de purina para utilização como agonistas do recetor de adenosina a2a | |
BR0309670A (pt) | Compostos derivados dicetohidrazina e drogas contendo os compostos como o ingrediente ativo | |
UA87123C2 (uk) | Водна суспензія циклесоніду для аерозольного розпилення | |
BRPI0409427A (pt) | composto, uso do mesmo, composição farmacêutica, método de tratamento de um humano sofrendo de uma doença hiperproliferativa, e, processo para a preparação de um composto ou de um sal, éster ou pró-droga farmaceuticamente aceitáveis do mesmo | |
NO20075111L (no) | Farmasoytisk sammensetning | |
HRP20130007T1 (hr) | Lijeäśenje kognitivnih poremeä†aja pomoä†u (r)-7-kloro-n-(kinuklidin-3-il)benzo[b]tiofen-2-karboksamida i njegovih farmaceutski prihvatljivih soli | |
BRPI0807285A2 (pt) | "composição, método para preparar composição farmacêutica, forma unitária de dosagem, método para admnistrar um agente biologicamente ativo a um animal necessitando o agente, método para aumentar a biodisponibilidade de um agente biologicamente ativo, método para preparar uma composição e composto" | |
WO2007057221A3 (en) | Pharmaceutical compositions for the treatment of inflammatory and obstructive airways diseases | |
DE602006017728D1 (de) | Krebsbehandlung mittels fts und 2-deoxyglucose | |
JP2009544665A5 (hr) | ||
AR064543A1 (es) | Uso de derivados de mononitrato de dianhidrohexita como agentes para el tratamiento de trastornos intestinales |